Clinical trial Recruiting at 1 site Observational Ages 18 and up

Homocysteine levels and early heart relaxation changes in newly diagnosed high blood pressure

Official title: Relationship Between Elevated Homocysteine Levels and Early Diastolic Dysfunction in Newly Diagnosed Hypertensive Patients

Run by Necmettin Erbakan University · NCT07480265 · Data updated 2026-11-12

See if higher blood homocysteine is linked to early diastolic (heart relaxation) problems in adults recently diagnosed with high blood pressure.

More Hypertension (HTN) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorNecmettin Erbakan University
Academic / other
Locations1 site (Konya, Meram)
StatusRecruiting
StartedJune 2, 2025
Main results expectedDecember 2027
Study endsMarch 2028
Registry record updatedMarch 24, 2026
Trial IDNCT07480265 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with a new diagnosis of essential hypertension within the past six months who can complete clinic visits, ambulatory blood pressure monitoring, blood draws, ECG, and transthoracic echocardiography are ideal candidates.

Probably not a fit

Patients with resistant or secondary hypertension, known heart failure, atrial fibrillation/flutter, chronic kidney disease, current folate/B12/B6 supplementation, or inadequate echocardiographic image quality are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center observational cohort enrolling at least 500 adults diagnosed with essential hypertension within the previous six months. Participants undergo clinical evaluation, ambulatory blood pressure monitoring, ECG, laboratory testing including pooled plasma homocysteine measurement, and comprehensive transthoracic echocardiography with diastolic function and strain analysis when image quality permits. Participants are categorized by a homocysteine threshold of 15 µmol/L and groups are compared for diastolic dysfunction and left ventricular and atrial global longitudinal strain parameters. Clinical, laboratory, and echocardiographic data will also be used to develop a machine-learning model to help predict H-type hypertension.

Why it matters

Potential benefit: If successful, the findings could help identify people with new high blood pressure who already have subtle heart dysfunction so clinicians can monitor or treat them earlier.

How similar studies have gone: Prior studies have linked elevated homocysteine to vascular and myocardial injury, but few large prospective cohorts have specifically tested its association with early diastolic dysfunction in newly diagnosed hypertension, so the approach is partly supported but still relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older
* Newly diagnosed essential hypertension within the previous 6 months
* Ability and willingness to provide informed consent
* Availability for clinical evaluation, laboratory testing, ambulatory blood pressure monitoring, electrocardiography, and transthoracic echocardiography

Exclusion Criteria:

* Resistant hypertension
* Secondary hypertension
* Acute coronary syndrome within the previous 6 months
* Major surgery within the previous 6 months
* Known heart failure
* Pulmonary hypertension
* Congenital heart disease
* Atrial fibrillation or atrial flutter
* Moderate or severe valvular heart disease
* Chronic kidney disease
* Anemia
* Current folate, vitamin B12, or vitamin B6 supplementation or treatment
* Inadequate echocardiographic image quality for strain analysis
* Known systemic conditions that may significantly affect plasma homocysteine levels

Where it's running

  • Necmettin Erbakan University Meram Faculty of Medicine
    Konya, Meram, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.